Xinermei (mazdutide) - Eli Lilly
Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME) (clinicaltrials.gov) - Sep 23, 2026 - P4 | N=60 | Recruiting | Sponsor: West China Hospital | Not yet recruiting ➔ Recruiting | Phase classification: P2/3 ➔ P4 | Trial completion date: Aug 2028 ➔ Aug 2029 | Trial primary completion date: Aug 2028 ➔ Feb 2029 
Enrollment open • Phase classification • Trial completion date • Trial primary completion date • Hepatology • Metabolic Disorders • Metabolic Dysfunction-Associated Steatohepatitis • Metabolic Dysfunction-Associated Steatotic Liver Disease • Obesity
http://clinicaltrials.gov/ct2/show/NCT07718126
 
Sep 23, 2026
 
Prev Next